Metabolic
Credibility 96
Impact of BMI on response to Janus kinase inhibitors in rheumatoid arthritis: an individual patient data meta-analysis of randomised controlled trials.
September 3, 2026 · The Lancet. Rheumatology
Key takeaway
For our community, this study found that if you have rheumatoid arthritis and are on certain medications (JAK inhibitors), having a higher BMI (weight for height) means the medicine might not work as well. This is important because obesity is more common in our community and could affect how well treatments help with joint pain.
Why this matters for our communities
Research in metabolic helps close long-standing gaps in how Black and African American families are studied, diagnosed, and cared for. Use findings like this one to start informed conversations with your care team — not as a substitute for personal medical advice.
More in Metabolic
December 31, 2026"Sometimes it's the bullying": an exploratory qualitative study of church leaders' perceptions of dietary health of black American children and youth.Read December 31, 2026What unhealthy food and beverage advertisements appeal to- and promote obesity amongst- adolescent children in urban South Africa?Read December 6, 2026Program and Family Predictors of Retention and Weight Loss Among Black Youth in a Pediatric Weight Management Program.Read